Bullfrog AI Holdings, Inc. (NASDAQ:BFRG – Get Free Report) was the recipient of a significant increase in short interest during the month of April. As of April 15th, there was short interest totalling 501,500 shares, an increase of 47.7% from the March 31st total of 339,500 shares. Approximately 7.3% of the shares of the company are short sold. Based on an average daily volume of 1,010,000 shares, the days-to-cover ratio is presently 0.5 days.
Insider Transactions at Bullfrog AI
In related news, CEO Vininder Singh sold 27,958 shares of the stock in a transaction that occurred on Thursday, April 3rd. The shares were sold at an average price of $1.44, for a total value of $40,259.52. Following the transaction, the chief executive officer now owns 2,348,341 shares in the company, valued at approximately $3,381,611.04. This represents a 1.18 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 33.90% of the company’s stock.
Institutional Inflows and Outflows
Large investors have recently bought and sold shares of the stock. Raymond James Financial Inc. purchased a new position in shares of Bullfrog AI during the 4th quarter valued at approximately $30,000. Two Sigma Securities LLC acquired a new stake in Bullfrog AI during the fourth quarter valued at $41,000. Finally, Geode Capital Management LLC increased its holdings in Bullfrog AI by 31.0% in the fourth quarter. Geode Capital Management LLC now owns 47,093 shares of the company’s stock valued at $94,000 after buying an additional 11,140 shares in the last quarter. 0.96% of the stock is owned by institutional investors and hedge funds.
Bullfrog AI Price Performance
Bullfrog AI (NASDAQ:BFRG – Get Free Report) last announced its quarterly earnings results on Friday, March 14th. The company reported ($0.18) earnings per share for the quarter.
Bullfrog AI Company Profile
Bullfrog AI Holdings, Inc, through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. The company offers bfLEAP, an analytical AI/ML platform for the analysis of preclinical and/or clinical data.
Featured Articles
- Five stocks we like better than Bullfrog AI
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Don’t Be Fooled by the Bounce: The Market Storm Isn’t Over Yet
- What is the Nasdaq? Complete Overview with History
- Coca-Cola Company Stock Can Bubble to New Highs This Year
- 3 Stocks to Consider Buying in October
- 3 Stocks Lifting 2025 Guidance Despite Market Jitters
Receive News & Ratings for Bullfrog AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bullfrog AI and related companies with MarketBeat.com's FREE daily email newsletter.